Biotech

All Articles

' Medical intuitiveness' led FDA consultants to back Zevra's uncommon ailment med

.Zevra Rehabs' unusual disease drug seems to become on the road to confirmation this autumn after ac...

Pfizer takes $230M reached after axing failed DMD genetics therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene therapy failing has blown a $230 million h...

AC Immune sees 'landmark' prospective in Alzheimer's medicine records

.After greater than two decades of deal with neurodegenerative illness, Swiss biotech hvac Immune in...

GSK falls ph. 2 HPV vaccine over shortage of best-in-class possible

.GSK has actually ditched a stage 2 individual papillomavirus (HPV) vaccine from its pipeline after ...

OS Treatments refiles $6M IPO to money HER2 medicine, preclinical ADCs

.OS Therapies will note on the NYSE American supply exchange today by means of a $6.4 thousand IPO t...

ALX's waning CD47 response cost sends out supply spiraling down

.ALX Oncology's phase 2 gastric cancer feedback cost has actually diminished. After viewing its own ...

Ionis axes eye ailment from targets of Roche-partnered possibility after information dissatisfy

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed require...

Biogen's chief executive officer pointed out no dangerous sell 2023. He prepares to be bold

.While Biogen's pharma peers are seeking for late-stage assets along with little threat, chief execu...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been actually a biotech searching for a pipe after it ditched its lea...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back civil rights to a very early Alzheimer's condition system to Denali...